HSBC Holdings’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Sell
21,400
-16,700
-44% -$1.29M ﹤0.01% 1647
2025
Q4
$3.03M Buy
38,100
+5,300
+16% +$418K ﹤0.01% 1411
2025
Q3
$2.45M Buy
32,800
+20,000
+156% +$1.37M ﹤0.01% 1425
2025
Q2
$877K Buy
+12,800
New +$839K ﹤0.01% 1862
2024
Q4
Sell
-12,600
Closed -$792K 3120
2024
Q3
$792K Hold
12,600
﹤0.01% 1796
2024
Q2
$735K Sell
12,600
-33,000
-72% -$2.06M ﹤0.01% 1802
2024
Q1
$3.64M Buy
45,600
+29,700
+187% +$2.27M ﹤0.01% 1220
2023
Q4
$1.25M Buy
+15,900
New +$1.13M ﹤0.01% 1672
2023
Q3
Sell
-2,800
Closed -$194K 2741
2023
Q2
$194K Sell
2,800
-25,600
-90% -$1.82M ﹤0.01% 2332
2023
Q1
$2.11M Sell
28,400
-173,000
-86% -$14.5M ﹤0.01% 1487
2022
Q4
$18.7M Buy
201,400
+25,100
+14% +$2.42M 0.02% 684
2022
Q3
$17.1M Sell
176,300
-7,000
-4% -$693K 0.03% 607
2022
Q2
$17.1M Buy
183,300
+70,500
+63% +$6.88M 0.02% 636
2022
Q1
$11.5M Sell
112,800
-15,800
-12% -$1.66M 0.01% 827
2021
Q4
$13.3M Buy
128,600
+17,900
+16% +$1.65M 0.01% 830
2021
Q3
$9.44M Buy
110,700
+1,900
+2% +$159K 0.01% 905
2021
Q2
$9.07M Buy
108,800
+91,200
+518% +$7.47M 0.01% 890
2021
Q1
$1.34M Sell
17,600
-96,500
-85% -$7.03M ﹤0.01% 1467
2020
Q4
$7.72M Buy
114,100
+50,500
+79% +$3.28M 0.01% 863
2020
Q3
$3.75M Buy
+63,600
New +$3.96M 0.01% 1059
2020
Q2
Sell
-85,100
Closed -$5.02M 2695
2020
Q1
$5.02M Buy
85,100
+25,700
+43% +$1.72M 0.01% 836
2019
Q4
$4.4M Sell
59,400
-361,400
-86% -$25.4M 0.01% 1157
2019
Q3
$26.5M Buy
420,800
+45,200
+12% +$2.68M 0.05% 432
2019
Q2
$20.5M Buy
375,600
+323,400
+620% +$17.4M 0.04% 493
2019
Q1
$2.81M Sell
52,200
-156,500
-75% -$9.66M 0.01% 1355
2018
Q4
$13.7M Buy
208,700
+206,700
+10,335% +$15.4M 0.03% 657
2018
Q3
$157K Hold
2,000
﹤0.01% 2456
2018
Q2
$129K Sell
2,000
-29,500
-94% -$1.94M ﹤0.01% 2490
2018
Q1
$1.96M Buy
+31,500
New +$2.26M ﹤0.01% 1431
2017
Q4
Sell
-8,100
Closed -$659K 2108
2017
Q3
$659K Sell
8,100
-164,400
-95% -$13M ﹤0.01% 1628
2017
Q2
$13.9M Buy
172,500
+40,100
+30% +$3.17M 0.03% 629
2017
Q1
$10.4M Sell
132,400
-157,100
-54% -$12.5M 0.02% 702
2016
Q4
$22.8M Buy
289,500
+198,600
+218% +$16.1M 0.05% 431
2016
Q3
$8.09M Buy
90,900
+33,900
+59% +$3.2M 0.02% 746
2016
Q2
$5.46M Buy
57,000
+54,600
+2,275% +$5.44M 0.02% 879
2016
Q1
$249K Sell
2,400
-42,900
-95% -$4.17M ﹤0.01% 1834
2015
Q4
$4.43M Buy
+45,300
New +$4.44M 0.01% 987
2015
Q2
Sell
-13,700
Closed -$1.41M 2105
2015
Q1
$1.41M Buy
13,700
+2,900
+27% +$293K ﹤0.01% 1268
2014
Q4
$1.05M Hold
10,800
﹤0.01% 1315
2014
Q3
$860K Buy
10,800
+10,600
+5,300% +$836K ﹤0.01% 1361
2014
Q2
$15K Hold
200
﹤0.01% 1746
2014
Q1
$15K Sell
200
-114,900
-100% -$8.12M ﹤0.01% 1702
2013
Q4
$8.24M Sell
115,100
-2,900
-2% -$186K 0.02% 692
2013
Q3
$6.7M Buy
+118,000
New +$7.03M 0.02% 747

Other funds holding CVS

HSBC Holdings's CVS Position: Q1 2026 in Review

HSBC Holdings increased its CVS Health (CVS) stake by 6.2% in Q1 2026, buying an estimated $10.9M and bringing the position to 2,410,694 shares worth $173M. The position accounts for 0.09% of the portfolio, ranked #217.

HSBC Holdings first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $253M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • HSBC Holdings held 2,410,694 shares of CVS Health worth $173M as of Q1 2026.
  • HSBC Holdings bought 140,893 CVS Health shares in Q1 2026, an estimated $10.9M.
  • CVS Health made up 0.09% of HSBC Holdings's portfolio in Q1 2026, its #217 holding.
  • HSBC Holdings first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's CVS Health position peaked at $253M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.